Historical record - last NADAC effective date: 8/23/2023
Product Information
ACYCLOVIR 400 MG TABLET is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.1022 per EA under NDC 69117001802. Its NADAC has been published 263 times since Aug 15, 2018.
FDA first approved this application on Mar 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Yiling Pharmaceutical Inc.NDC
69117001802
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
ACYCLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA210401FDA Approved
3/7/2018
TE Code
AB
On Market Since
5/4/2018
Pharmacological Classes
Price Statistics
The NADAC for ACYCLOVIR 400 MG TABLET has been published 263 times since Aug 15, 2018, and over the history we have for it it has risen 20.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1022 per EA |
|---|---|
| All-time high | $0.1245 (Jan 13, 2021) |
| All-time low | $0.0701 (Apr 17, 2019) |
| Median price | $0.1000 |
| Average price | $0.0962 |
| Largest weekly change | +10.9% (Sep 23, 2020) |
| Weeks tracked | 263 |
| Tracking since | Aug 15, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-5.5%
All
+20.2%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Yiling Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acyclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACYCLOVIR 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 400 MG TABLET, manufactured by Yiling Pharmaceutical Inc., is $0.1022 per EA (NDC 69117001802), effective Aug 23, 2023.
How has the price of ACYCLOVIR 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACYCLOVIR 400 MG TABLET has risen 20.2%. It has been tracked across 263 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for ACYCLOVIR 400 MG TABLET?
Since Aug 15, 2018, the NADAC for ACYCLOVIR 400 MG TABLET has ranged from a low of $0.0701 (Apr 17, 2019) to a high of $0.1245 (Jan 13, 2021), with a median of $0.1000 per EA.
Are there cheaper alternatives to ACYCLOVIR 400 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACYCLOVIR 400 MG TABLET, is $0.0779 per EA — about 24% below ACYCLOVIR 400 MG TABLET.
Who manufactures ACYCLOVIR 400 MG TABLET?
ACYCLOVIR 400 MG TABLET (NDC 69117001802) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.